24Q1扭亏为盈，海外重组蛋白业务即将收获
KEXING BIOPHARM CO.(SH:688136) Huaan Securities·2024-04-30 14:00| --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...